Trinity Biotech plc (TRIB) is a publicly traded Healthcare sector company. As of September 8, 2026, TRIB trades at $9.08 with a market cap of $7.65M and a P/E ratio of 0.00. TRIB moved +0.00% today. Year to date, TRIB is -60.35%; over the trailing twelve months it is -72.96%. Its 52-week range spans $7.94 to $103.20. Rallies surfaces TRIB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks TRIB insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $9.08 |
| Market Cap | $7.65M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.22% |
| 52-Week High | $103.20 |
| 52-Week Low | $7.94 |
| Volume | 9.94K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
TRIB analyst coverage data. Average price target: $0.00.